NCT01119079

Brief Summary

In current obstetric anesthesia practice, epidural analgesia is the most effective technique to control labor pain for those women who request pain-free delivery. Epidural analgesia not only allows us to obtain greater pain relief and increased satisfaction of mothers, but also permits us to convert it to regional anesthesia in case of operative delivery, avoiding general anesthesia. One of the major concerns with epidural anesthesia in labor setting is the inability to produce an intensive analgesia or adequate level to proceed with cesarean section. This study is designed to examine the hypothesis that 10ml epidural normal saline to reduce rate of one-side block, low segmental block, and patch block, and improve quality of labor epidural analgesia/ anesthesia in obstetric population.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Mar 2010

Typical duration for phase_3

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2010

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 6, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 7, 2010

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2012

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2012

Completed
Last Updated

April 24, 2015

Status Verified

April 1, 2015

Enrollment Period

2.3 years

First QC Date

May 6, 2010

Last Update Submit

April 23, 2015

Conditions

Keywords

labor painepidural

Outcome Measures

Primary Outcomes (1)

  • improve quality of labor epidural analgesia/ anesthesia in obstetric population.

    Administration of epidural anesthesia + 2 hours

Study Arms (2)

Standard labor epidural protocol

PLACEBO COMPARATOR

Standard labor epidural protocol

Procedure: Administration of epidural anesthesia for labor

10ml Normal Saline prior to lidocaine

EXPERIMENTAL
Other: Normal Saline

Interventions

10ml Normal Saline instilled in the epidural space

10ml Normal Saline prior to lidocaine

Standard procedure

Standard labor epidural protocol

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • American Society of Anesthesiologists class I-II term parturients with singleton vertex presentation in active labor
  • Patients who have cervical dilatation between 3 and 7 centimeters

You may not qualify if:

  • Patients with contraindications to epidural analgesia,
  • severe medical or obstetric complications,
  • morbid obesity (body mass index \>40 kg/m2),
  • history of drug or alcohol abuse,
  • abnormal hepatic (AST/ALT), renal (creatinine levels), or hematological (PTT levels) test results.
  • presence of blood on the second insertion into the intervertebral space
  • presence of cerebral spinal fluid upon insertion into the intervertebral space
  • subjects who deliver (either vaginally or via cesarean section) within 2 hours of the epidural insertion
  • subjects less than 36 weeks gestation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital

Newark, New Jersey, 07101, United States

Location

MeSH Terms

Conditions

Labor Pain

Interventions

Saline Solution

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Crystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Study Officials

  • Dongchen Li, MD, PhD

    UMDNJ-NJMS

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 6, 2010

First Posted

May 7, 2010

Study Start

March 1, 2010

Primary Completion

June 1, 2012

Study Completion

September 1, 2012

Last Updated

April 24, 2015

Record last verified: 2015-04

Locations